“Companies are realizing that investing stateside can provide more control and resilience to the drug supply chain,” says ...
In a recent article titled “ Big Pharma says ‘Thanks, but No Thanks’ to their own HEOR groups, ” Professor Scott Ramsey from ...
A local nonprofit is eyeing a downtown move. FirstDay Foundation has acquired the office building at 318 McCullough Ave.
B.well Connected Health, maker of a platform unifying patient data, picked up an additional investment from nonprofit ...
If you're focused on delivering a high return on capital for your shareholders, you should consider M&A as an integral part ...
While foreign investors have been reducing their exposure to Indian pharma, some leading domestic institutional investors ...
The key difference lies in the neural network structure. In any AI system ... It’s truly remarkable that a pharmaceutical company is at the forefront of developing fundamental new AI technology that ...
Good afternoon, and welcome to the Ultragenyx Fourth Quarter and Full Year 2024 Financial Results Conference Call. At this time, all participants are in a listen-only-mode. At the end of the prepared ...
The laboratory of the latest Nobel Prize winner in Chemistry David Baker, headed by researcher Susana Vázquez, talks about ‘democratizing’ the discovery of therapies ...
Preliminary data indicates patients experienced either a complete cure or significant improvement in infection symptoms following treatment with ...
Party General Secretary To Lam on February 6 held a working session with the Ha Giang provincial Party Committee to review ...
The three-day conference will address crucial topics related to pharmaceutical regulation, impurity assessment, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results